Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT06692660
Starting soon Observational

Overview: Use of Respiratory Support At Home in Children

NCT06692660 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2024-11
Last updated
2024-11-18

Condition(s) studied

Sleep Apnea Syndromes in ChildrenObesity in ChildrenBronchopulmonary Dysplasia (BPD)Neuromuscular DiseaseStorage DiseaseMalformationAlveolar Hypoventilation

Study summary

the primary outcome is to describe the perceived success of the use of the respiratory support from the parent's point of view

Eligibility

Sex
ALL
Min age
0 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Children with respiratory support at home * Age 0 to 18 (not yet passed) years old Exclusion Criteria: * Palliative care * Invasive ventilation * High flow oxygen therapy

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Centre Hospitalier Universitaire Grenoble Alpes Grenoble Isère
Centre Hospitalier Grenoble Alpes La Tronche France

More University Hospital, Grenoble trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06692660 on ClinicalTrials.gov ↗ ← All trials in France